Retatrutide Pen

Retatrutide is a next-generation triple agonist that hits the GIP, GLP-1, and glucagon receptors at once — the trifecta drawing the most interest in metabolic research. It is studied for powerful appetite reduction, sustained weight loss, and steadier blood sugar on a once-weekly cadence. Delivered as a prefilled, click-dose self-injection pen — compounded in a US-licensed pharmacy and shipped cold-chain. Refrigerator-stable; store at 2–8°C. For use under licensed-provider supervision.